This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Pfizer Corporation. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2020
Title: Innovator Spotlight: Timothy Scott Fisher in San Diego
Introduction
Timothy Scott Fisher, based in San Diego, California, is a notable inventor with a keen focus on biopharmaceutical innovations. With an impressive portfolio of four patents, Fisher is making significant contributions to the field of binding molecules, particularly those that target human 4-1BB, which plays a crucial role in immune regulation.
Latest Patents
Fisher's recent patents center around the development of isolated binding molecules that specifically bind to human 4-1BB. His work includes the creation of nucleic acid molecules encoding the amino acid sequence of these binding molecules, along with the formulation of pharmaceutical compositions that incorporate them. The methods described in his patents outline how to produce these binding molecules and their associated nucleic acids, potentially paving the way for innovative therapeutic approaches in immunotherapy.
Career Highlights
Timothy Fisher is currently employed at Pfizer Corporation, a renowned leader in the pharmaceutical industry. His work at Pfizer has allowed him to leverage his expertise in molecular biology and immunology, facilitating advancements in the development of novel therapeutic agents. Fisher’s dedication to research and innovation has positioned him as a vital asset to his team and the larger scientific community.
Collaborations
Within the dynamic environment at Pfizer, Fisher collaborates with talented colleagues, including Bianca Ahrens and Sangita M. Baxi. Their collective efforts foster a culture of innovation, driving forward the research and development of impactful therapeutic solutions.
Conclusion
Timothy Scott Fisher exemplifies the spirit of innovation in the biopharmaceutical sector. His groundbreaking patents related to 4-1BB binding molecules highlight not just his inventive spirit, but also the collaboration and teamwork essential in bringing transformative medical advancements to fruition. With ongoing research, Fisher's contributions are likely to have a lasting impact on the future of immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile